نتائج البحث

An international assessment of the adoption of enhanced recovery after surgery (ERAS®) principles across colorectal units in 2019-2020

• Authors : Pinkney, T; Taylor, H; Tong, C

Subjects: Medicin och hälsovetenskap

• Source: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 23(11):2980-2987

تفاصيل العنوان

Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: Final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial

• Authors : Coleman R. L.; Lorusso D.; Oaknin A. ...

Subjects: Ovarian Cancer; Ovarian Neoplasm

تفاصيل العنوان

Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis

• Authors : Bartoletti M.; Montico M.; Lorusso D. ...

Subjects: Endometrial cancer; Immunotherapy; Meta-analysis

تفاصيل العنوان

Randomised phase II BGOG/ENGOT-CX1 study of Paclitaxel-Carboplatin with or without Nintedanib in first-line recurrent or advanced cervical cancer

• Authors : Vergote, IB; Van Nieuwenhuysen, E; Casado, A

Subjects: Paclitaxel-Carboplatin; Nintedanib; cervical cancer

تفاصيل العنوان

Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer

• Authors : Arends, C.M.; Kopp, K.; Hablesreiter, R.

Subjects: Cancer Research

تفاصيل العنوان

102P A retrospective description of actionable mutations incidence within a comprehensive cancer genome profiling programme: Is less still more?

• Authors : Camarda, F.; Nero, C.; Giacomini, F.

Subjects: Cancer Research; Oncology

• Source: ESMO Open ; volume 9, page 102328 ; ISSN 2059-7029

تفاصيل العنوان

European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer

• Authors : Vergote, I.; González-Martín, A.; Ray-Coquard, I.

Subjects: BRCA1/2; PARP inhibition; genetic counselling

• Source: Annals of Oncology. 33(3):276-287

تفاصيل العنوان

Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data

• Authors : Agostinelli V; Musacchio L; Camarda F

Subjects: cervical cancer; gynecological cancer; antibody–drug conjugate

• Source: Cancer Management and Research, Vol Volume 15, Pp 1063-1072 (2023)

تفاصيل العنوان

Outcomes for patients (pts) with advanced endometrial cancer (aEC) who completed pembrolizumab (pembro) and continued lenvatinib (LEN) in the phase III Study 309/ KEYNOTE-775

• Authors : Lorusso, D.; Kim, Y. M.; Sanli, U. A.

تفاصيل العنوان

ESGO/ESTRO/ESP guidelines for the management of patients with cervical cancer - Update 2023

• Authors : Cibula, D. (David); Raspollini, M.R. (Maria Rosaria); Planchamp, F. (François)

Subjects: Mortality; Cervical cancer; Pathology

تفاصيل العنوان

Efficacy and safety of mirvetuximab soravtansine in patients with platinum-resistant ovarian cancer with high folate receptor alpha expression : results from the SORAYA study

• Authors : Matulonis, UA; Lorusso, D; Oaknin, A

Subjects: Medicine and Health Sciences

• Source: JOURNAL OF CLINICAL ONCOLOGY ; ISSN: 0732-183X ; ISSN: 1527-7755

تفاصيل العنوان

Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab

• Authors : Colombo, N.; Lorusso, D.; Monk, B.J. ...

Subjects: adverse reactions; endometrial cancer; lenvatinib

• Source: The oncologist

تفاصيل العنوان

Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer

• Authors : Moore, KN; Angelergues, A; Konecny, GE

Subjects: Female; Humans; Antibodies

• Source: New England Journal of Medicine , 389 (23) pp. 2162-2174. (2023)

تفاصيل العنوان

Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study.

• Authors : Vergote, I; Van Nieuwenhuysen, E; O'Cearbhaill, RE ...

Subjects: United States

تفاصيل العنوان

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

• Authors : Ray-Coquard, I.; Leary, A.; Pignata, S. ...

• Source: Annals of Oncology ; volume 34, issue 8, page 681-692 ; ISSN 0923-7534

تفاصيل العنوان

10P An adapted CGP-based model to interpret POLE mutations in endometrial cancer

• Authors : Trozzi, R.; Ottaviani, M.; Nero, C.

Subjects: Cancer Research; Oncology

• Source: ESMO Open ; volume 8, issue 1, page 101656 ; ISSN 2059-7029

تفاصيل العنوان

96P Analysis of concordance between microsatellite instability by next generation sequencing (NGS-MSI) and mismatch repair deficiency by immunohistochemistry (IHC-MMR) in endometrial cancer (EC) patients

• Authors : Duranti, S.; Camarda, F.; Nero, C.

Subjects: Cancer Research; Oncology

• Source: ESMO Open ; volume 8, issue 1, page 101906 ; ISSN 2059-7029

تفاصيل العنوان

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer

• Authors : Koppikar, S.; Oaknin, A.; Babu, K. Govind

Subjects: Cancer Research; Oncology

• Source: ESMO Open ; volume 8, issue 1, page 100774 ; ISSN 2059-7029

تفاصيل العنوان

33O PRIMA/ENGOT-OV26/GOG-3012 study: Long-term conditional PFS

• Authors : Gonzalez Martin, A.J.; Pothuri, B.; Vergote, I.B.

Subjects: Cancer Research; Oncology

• Source: ESMO Open ; volume 8, issue 1, page 100813 ; ISSN 2059-7029

تفاصيل العنوان

42P Efficacy of maintenance with PARPi in advanced ovarian cancer according to the location of BRCA mutation

• Authors : Marchetti, C.; Fagotti, A.; Cassani, C.

Subjects: Cancer Research; Oncology

• Source: ESMO Open ; volume 8, issue 1, page 100822 ; ISSN 2059-7029

تفاصيل العنوان

32O 5-year (y) overall survival (OS) with maintenance olaparib (ola) plus bevacizumab (bev) by clinical risk in patients (pts) with newly diagnosed advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial

• Authors : Lorusso, D.; Mouret-Reynier, M-A.; Harter, P.

Subjects: Cancer Research; Oncology

• Source: ESMO Open ; volume 8, issue 1, page 100812 ; ISSN 2059-7029

تفاصيل العنوان

52P Real-world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group

• Authors : Musacchio, L.; Palluzzi, E.; Lauria, R.

Subjects: Cancer Research; Oncology

• Source: ESMO Open ; volume 8, issue 1, page 100832 ; ISSN 2059-7029

تفاصيل العنوان

12P Tisotumab vedotin in recurrent or metastatic cervical cancer

• Authors : Bini, M.; Bogani, G.; Coleman, R.L.

Subjects: Cancer Research; Oncology

• Source: ESMO Open ; volume 8, issue 1, page 100867 ; ISSN 2059-7029

تفاصيل العنوان

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

• Authors : Coleman, Robert L; Oza, Amit M; Lorusso, Domenica

Subjects: Reproductive Medicine; Biomedical and Clinical Sciences; Oncology and Carcinogenesis

• Source: The Lancet. 390(10106)

تفاصيل العنوان

Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital

• Authors : Bizzarri N.; Nero C.; Sillano F. ...

Subjects: gynecologic oncology; Patient-centered care; Personalized medicine

تفاصيل العنوان

Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies

• Authors : Russo A.; Incorvaia L.; Capoluongo E. ...

Subjects: BRCA testing; BRCA-related cancer; BRCA1

تفاصيل العنوان

Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer

• Authors : Bartoletti M.; Pignata S.; Lorusso D. ...

تفاصيل العنوان

Deep Neural Network Integrated into Network-Based Stratification (D3NS): A Method to Uncover Cancer Subtypes from Somatic Mutations.

• Authors : Valerio M; Medical Oncology, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella, Verona, Italy.; Inno A

• Source: Cancers [Cancers (Basel)] 2024 Aug 14; Vol. 16 (16). Date of Electronic Publication: 2024 Aug 14.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print)

تفاصيل العنوان

Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer.

• Authors : Olawaiye AB; University of Pittsburgh School of Medicine and Magee-Womens Hospital, Gynecologic Oncology Group, Pittsburgh, PA, USA. .; Kim JW

Subjects: Albumins*/Albumins*/Albumins*/administration & dosage ; Albumins*/Albumins*/Albumins*/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use

• Source: Journal of gynecologic oncology [J Gynecol Oncol] 2024 Jul; Vol. 35 (4), pp. e111.Publisher: Asian Society of Gynecologic Oncology Country of Publication: Korea (South) NLM ID: 101483150 Publication Model: Print Cited Medium:

تفاصيل العنوان

Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial

• Authors : Capoluongo ED; Pellegrino B; Arenare L

Subjects: RD; HRR; Myriad

تفاصيل العنوان

Quality-adjusted time without symptoms of disease or toxicity and quality-adjusted progression-free survival with niraparib maintenance in first-line ovarian cancer in the PRIMA trial

• Authors : Barretina-Ginesta, M.-P.; Monk, B.J.; Han, S. ...

Subjects: maintenance therapy; niraparib; ovarian cancer

• Source: Therapeutic Advances in Medical Oncology

تفاصيل العنوان

Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

• Authors : Vergote, I; Gonzalez-Martin, A; Lorusso, D

Subjects: Carcinoma; Ovarian Epithelial; Consensus

• Source: The Lancet Oncology , 23 (8) e374-e384. (2022)

تفاصيل العنوان

Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

• Authors : Oaknin, A; Bosse, TJ; Creutzber, CL

Subjects: endometrial cancer; ESMO Clinical Practice Guideline; diagnosis

• Source: Annals of Oncology , 33 (9) pp. 860-877. (2022)

تفاصيل العنوان

A randomized, phase III trial to evaluate rucaparib monotherapy as maintenance treatment in patients with newly diagnosed ovarian cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)

• Authors : Monk, BJ; Parkinson, C; Lim, MC ...

Subjects: Oncology & Carcinogenesis; 1103 Clinical Sciences; 1112 Oncology and Carcinogenesis

• Source: 3964 ; 3592

تفاصيل العنوان

178O Rucaparib maintenance treatment in patients (pts) with newly diagnosed ovarian cancer (OC): Defining benefit according to disease risk subgroups within the phase III ATHENA–MONO study

• Authors : Fujiwara, K.; Kristeleit, R.; Ghamande, S.

Subjects: Oncology; Hematology

• Source: Annals of Oncology ; volume 33, page S1505-S1506 ; ISSN 0923-7534

تفاصيل العنوان

27P Clinical relevance of NGS analysis in endometrial cancer (EC) management

• Authors : Giudice, E.; Ghizzoni, V.; Carbone, M.V.

Subjects: Oncology; Hematology

• Source: Annals of Oncology ; volume 33, page S1392 ; ISSN 0923-7534

تفاصيل العنوان

132P Genomic profiling of primary and recurrent ovarian cancers: A retrospective single-center experience

• Authors : Giudice, E.; Ghizzoni, V.; Carbone, M.V.

Subjects: Oncology; Hematology

• Source: Annals of Oncology ; volume 33, page S1424-S1425 ; ISSN 0923-7534

تفاصيل العنوان

527MO Rucaparib maintenance treatment in patients (pts) with newly diagnosed ovarian cancer (OC): Defining benefit according to disease risk subgroups within the phase 3 ATHENA–MONO study

• Authors : Kristeleit, R.; Ghamande, S.; Lim, M-C.

Subjects: Oncology; Hematology

• Source: Annals of Oncology ; volume 33, page S786-S787 ; ISSN 0923-7534

تفاصيل العنوان

528MO Is re-introduction or continuation of PARP inhibitors after local therapy for oligo-metastatic progression in patients with relapsed ovarian cancer relevant?

• Authors : Thibault, G.; Kfoury, M.; Lorusso, D.

Subjects: Oncology; Hematology

• Source: Annals of Oncology ; volume 33, page S787-S788 ; ISSN 0923-7534

تفاصيل العنوان

605P Population pharmacokinetic (PK) analysis of mirvetuximab soravtansine (MIRV) in patients with folate receptor α (FRα)-positive cancer

• Authors : Moore, K.N.; Lorusso, D.; Oaknin, A.

Subjects: Oncology; Hematology

• Source: Annals of Oncology ; volume 33, page S822-S823 ; ISSN 0923-7534

تفاصيل العنوان

518O Overall survival results from ARIEL4: A phase III study assessing rucaparib vs chemotherapy in patients with advanced, relapsed ovarian carcinoma and a deleterious BRCA1/2 mutation

• Authors : Oza, A.M.; Lisyanskaya, A.S.; Fedenko, A.A.

Subjects: Oncology; Hematology

• Source: Annals of Oncology ; volume 33, page S780 ; ISSN 0923-7534

تفاصيل العنوان

524MO Glucocorticoid receptor expression and activity in a phase II ovarian cancer trial of the glucocorticoid receptor modulator relacorilant in combination with nab-paclitaxel

• Authors : Lorusso, D.; Greenstein, A.E.; Wadekar, S.A.

Subjects: Oncology; Hematology

• Source: Annals of Oncology ; volume 33, page S784-S785 ; ISSN 0923-7534

تفاصيل العنوان

592P Exposure response (ER) analysis for efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with folate receptor α (FRα)-positive cancer

• Authors : Matulonis, U.A.; Moore, K.N.; Lorusso, D.

Subjects: Oncology; Hematology

• Source: Annals of Oncology ; volume 33, page S817 ; ISSN 0923-7534

تفاصيل العنوان

536P Relacorilant + nab-paclitaxel in patients with recurrent, platinum-resistant ovarian cancer: Phase II subgroup analysis mirroring the patient population of an upcoming phase III study

• Authors : Colombo, N.; Van Gorp, T.; Matulonis, U.A.

Subjects: Oncology; Hematology

• Source: Annals of Oncology ; volume 33, page S793 ; ISSN 0923-7534

تفاصيل العنوان

525MO Updated efficacy and safety of lenvatinib (LEN) + pembrolizumab (pembro) vs treatment of physician’s choice (TPC) in patients (pts) with advanced endometrial cancer (aEC): Study 309/KEYNOTE-775

• Authors : Makker, V.; Colombo, N.; Casado Herraez, A.

Subjects: Oncology; Hematology

• Source: Annals of Oncology ; volume 33, page S785-S786 ; ISSN 0923-7534

تفاصيل العنوان

519MO Phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial of cemiplimab in recurrent or metastatic (R/M) cervical cancer: Long-term survival analysis

• Authors : Oaknin, A.; Monk, B.J.; Polastro, L.

Subjects: Oncology; Hematology

• Source: Annals of Oncology ; volume 33, page S781 ; ISSN 0923-7534

تفاصيل العنوان

532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011)

• Authors : Moore, K.N.; Oza, A.M.; Colombo, N.

Subjects: Oncology; Hematology

• Source: Annals of Oncology ; volume 33, page S790-S791 ; ISSN 0923-7534

تفاصيل العنوان

Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

• Authors : Oaknin, A.; Bosse, T.J.; Creutzberg, C.L.

• Source: Annals of Oncology ; volume 33, issue 9, page 860-877 ; ISSN 0923-7534

تفاصيل العنوان

530P PRIMA/ENGOT-OV26/GOG-3012 study: Updated long-term PFS and safety

• Authors : Gonzalez Martin, A.J.; Pothuri, B.; Vergote, I.B.

Subjects: Oncology; Hematology

• Source: Annals of Oncology ; volume 33, page S789 ; ISSN 0923-7534

تفاصيل العنوان

31P Survival outcomes in BRCA pathogenetic mutated, variant of unknown significance, and wild type ovarian cancer patients treated with PARP inhibitors

• Authors : Musacchio, L.; Marchetti, C.; Boccia, S.M.

Subjects: Oncology; Hematology

• Source: Annals of Oncology ; volume 33, page S396 ; ISSN 0923-7534

تفاصيل العنوان